Arab Pharmaceuticals (ADCI)

Currency in EGP
232.77
+0.77(+0.33%)
Closed·
ADCI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
230.00234.70
52 wk Range
98.15249.98
Key Statistics
Bid/Ask
232.00 / 233.02
Prev. Close
232
Open
232.19
Day's Range
230-234.7
52 wk Range
98.15-249.98
Volume
15.49K
Average Volume (3m)
46.01K
1-Year Change
120.7606%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADCI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 21, 2026
EPS / Forecast
4.49 / --
Revenue / Forecast
355.68M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 19.09%
Dividend Yield
3.55%
Industry Median 2.33%
Annualised payout
8.33
Paid annually
5-Years Growth
+27.22%
Growth Streak

ADCI Income Statement

Compare ADCI to Peers and Sector

Metrics to compare
ADCI
Peers
Sector
Relationship
P/E Ratio
12.2x11.9x−0.4x
PEG Ratio
0.270.270.00
Price/Book
4.1x2.6x2.6x
Price / LTM Sales
2.1x1.6x3.0x
Upside (Analyst Target)
-17.3%51.9%
Fair Value Upside
Unlock5.8%9.4%Unlock

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

Employees
1148
Market
Egypt

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
8.44M70.30%1.96B
Public Companies & Retail Investors
3.56M29.70%826.85M
Total
12M100.00%2.78B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
HoldiPharma60.30%7,236,0001,678,752
Arab Drug Comany, ESOP10.00%1,200,000278,400

People Also Watch

FAQ

What Is the Arab Pharma (ADCI) Stock Price Today?

The Arab Pharma stock price today is 232.77 EGP.

What Stock Exchange Does Arab Pharma Trade On?

Arab Pharma is listed and trades on the Egypt Stock Exchange.

What Is the Stock Symbol for Arab Pharma?

The stock symbol for Arab Pharma is "ADCI."

What Is the Arab Pharma Market Cap?

As of today, Arab Pharma market cap is 2.79B EGP.

What Is Arab Pharma's Earnings Per Share (TTM)?

The Arab Pharma EPS (TTM) is 19.09.

When Is the Next Arab Pharma Earnings Date?

Arab Pharma will release its next earnings report on Aug 29, 2025.

From a Technical Analysis Perspective, Is ADCI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Arab Pharma Stock Split?

Arab Pharma has split 5 times.

How Many Employees Does Arab Pharma Have?

Arab Pharma has 1148 employees.

What is the current trading status of Arab Pharma (ADCI)?

As of Jul 09, 2026, Arab Pharma (ADCI) is trading at a price of 232.77 EGP, with a previous close of 232.00 EGP. The stock has fluctuated within a day range of 230.00 EGP to 234.70 EGP, while its 52-week range spans from 98.15 EGP to 249.98 EGP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.